BEAM in the 13F filings
Beam Therapeutics Inc · CUSIP 07373V105
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 19 Feb 2026
- latest of these filings; the earliest 23 Jan 2026
- Managers listing it
- 26
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 6 listed it in both
- Shares listed
- 43,266,210
- combined, among listed positions
- Reported value
- $1.2bn
- combined, at the quarter end
Among the 92 comparable managers: 18 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +4,373,897.
Managers listing BEAM in Q4 2025
26 of 26 holders
Largest increases and reductions, by shares
Increases
- ARK Investment Management LLCexisting position · 12,467,189 shares now+1,428,355
- Marshall Wace LLPnew position · 945,829 shares now+945,829
- Two Sigma Investments LPexisting position · 1,120,389 shares now+741,345
- T. Rowe Price Associates Incexisting position · 2,730,282 shares now+467,133
- Woodline Partners LPexisting position · 993,066 shares now+446,507
Reductions
- Voloridge Investment Management LLCexisting position · 492,430 shares now-767,581
- Schonfeld Strategic Advisors LLCexisting position · 128,360 shares now-167,730
- Hudson Bay Capital Management LPexisting position · 15,000 shares now-55,000
- Susquehanna International Group LLPexisting position · 98,511 shares now-26,635
- Wellington Management Group LLPexisting position · 36,902 shares now-1,086
New positions and exits
New (8)
Exited (3)
- Man Group PLCwas $1.7m
- Brevan Howard Capital Management LPwas $1.2m
- Polen Capital Management LLCwas $222k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2020 | 1 | $3.1m | n.a. | n.a. |
| Q4 2020 | 4 | $705m | n.a. | n.a. |
| Q1 2021 | 6 | $1.1bn | n.a. | n.a. |
| Q2 2021 | 6 | $2.1bn | n.a. | n.a. |
| Q3 2021 | 5 | $769m | n.a. | n.a. |
| Q4 2021 | 3 | $818m | n.a. | n.a. |
| Q1 2022 | 4 | $620m | n.a. | n.a. |
| Q2 2022 | 4 | $457m | n.a. | n.a. |
| Q3 2022 | 5 | $610m | n.a. | n.a. |
| Q4 2022 | 4 | $481m | n.a. | n.a. |
| Q1 2023 | 4 | $397m | n.a. | n.a. |
| Q2 2023 | 3 | $394m | n.a. | n.a. |
| Q3 2023 | 4 | $351m | n.a. | n.a. |
| Q4 2023 | 4 | $389m | 2 | 3 |
| Q1 2024 | 4 | $446m | 2 | 3 |
| Q2 2024 | 3 | $379m | 1 | 3 |
| Q3 2024 | 3 | $370m | 1 | 2 |
| Q4 2024 | 4 | $394m | 3 | 1 |
| Q1 2025 | 5 | $419m | 4 | 1 |
| Q2 2025 | 5 | $358m | 4 | 1 |
| Q3 2025 | 7 | $571m | 5 | 2 |
| Q4 2025 | 6 | $692m | 18 | 8 |
| Q1 2026 | 3 | $540m | 14 | 13 |
| Q2 2026 | 3 | $713m | 17 | 8 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
BEAM and GILD →BEAM and AMGN →BEAM and ARGX →Choose a stock to compare with BEAM →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own BEAM, latest filings →Back to the 13F Explorer →